Clinical trial
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Evaluate Safety, Tolerability and Efficacy of Orally Administered ENT-01 for the Treatment of Parkinson's Disease-Related Constipation (KARMET)
NCT03781791 is registered in ClinicalTrials.gov with Enterin Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Evaluate Safety, Tolerability and Efficacy of Orally Administered ENT-01 for the Treatment of Parkinson's Disease-Related Constipation (KARMET)
- Lead sponsor
- Enterin Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 10, 2018
- Completion date
- December 14, 2021
- Enrollment
- 151 (actual)
- Sites
- 51
Conditions
As the registry lists them; a condition with its own page is linked.